Gladius Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,150
| Closed | -$5.86M | – | 346 |
|
|
2023
Q2 | $5.86M | Buy |
8,150
+3,223
| +65% | +$2.32M | 0.29% | 4 |
|
|
2023
Q1 | $4.05M | Buy |
+4,927
| New | +$4.05M | 0.24% | 9 |
|
|
2022
Q3 | – | Sell |
-15
| Closed | -$9K | – | 415 |
|
|
2022
Q2 | $9K | Buy |
+15
| New | +$9K | ﹤0.01% | 275 |
|
|
2022
Q1 | – | Sell |
-146
| Closed | -$93K | – | 239 |
|
|
2021
Q4 | $93K | Buy |
+146
| New | +$93K | 0.01% | 164 |
|